← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Medicines For Malaria Venture
Geneva
$11,454,352
Total funding
2
Grants
Funding over time
peak $2.4M · FY2007–15$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$11,454,352 · 2
By mechanism
R01$5,931,156 · 1
U01$5,523,196 · 1
Investigators at Medicines For Malaria Venture
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Validation of New Antimalarial Leads$1,238,884
R01 · FY2011 · AI
Validation of New Antimalarial Leads$1,190,932
R01 · FY2015 · AI
Validation of New Antimalarial Leads$1,190,932
R01 · FY2012 · AI
Validation of New Antimalarial Leads$1,190,932
R01 · FY2014 · AI
Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria$1,157,642
U01 · FY2011 · AI
Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria$1,137,983
U01 · FY2010 · AI
Validation of New Antimalarial Leads$1,119,476
R01 · FY2013 · AI
Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria$1,101,631
U01 · FY2009 · AI
Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria$1,069,709
U01 · FY2008 · AI
Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria$1,056,231
U01 · FY2007 · AI